Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node

Journal of Immunology

Volumn 179, Issue 4, 2007, Pages 2261-2269

  Matheu, Melanie P ^a   Deane, Jonathan A ^b   Parker, Ian ^a,b   Fruman, David A ^b   Cahalan, Michael D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; ENZYME INHIBITOR; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1A; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; WORTMANNIN; ISOENZYME; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; B LYMPHOCYTE; BASAL CELL; CATALYSIS; CELL MOTILITY; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPH NODE CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE HOMING; OVARY FOLLICLE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; CELL MOTION; CELL PROLIFERATION; ENZYME ACTIVE SITE; ENZYMOLOGY; HOMEOSTASIS; IMMUNOLOGY; KINETICS; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; B-LYMPHOCYTES; CATALYTIC DOMAIN; CELL MOVEMENT; CELL PROLIFERATION; HOMEOSTASIS; ISOENZYMES; KINETICS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES;

EID: 34848887428     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.4.2261     Document Type: Article

References (42)

1. Deane, J. A., and D. A. Fruman. 2004. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 22: 563-598.
2. Deane, J. A., M. J. Trifilo, C. M. Yballe, S. Choi, T. E. Lane, and D. A. Fruman. 2004. Enhanced T cell proliferation in mice lacking the p85β subunit of phosphoinositide 3-kinase. J. Immunol. 172: 6615-6625.
3. Suzuki, H., Y. Terauchi, M. Fujiwara, S. Aizawa, Y. Yazaki, T. Kadowaki, and S. Koyasu. 1999. Xid-like immunodeficiency in mice with disruption of the p85alpha; subunit of phosphoinositide 3-kinase. Science 283: 390-392.
4. Ward, S. G. 2004. Do phosphoinositide 3-kinases direct lymphocyte navigation? Trends Immunol. 25: 67-74.
5. Hannigan, M., L. Zhan, Z. Li, Y. Ai, D. Wu, and C. K. Huang. 2002. Neutrophils lacking phosphoinositide 3-kinase γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA 99: 3603-3608.
6. Wang, F. 2002. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat. Cell Biol. 4: 513-518.
7. Reif, K., K. Okkenhaug, T. Sasaki, J. M. Penninger, B. Vanhaesebroeck, and J. G. Cyster. 2004. Cutting edge: differential roles for phosphoinositide 3-kinases, p110γ. and p110δ, in lymphocyte chemotaxis and homing. J. Immunol. 173: 2236-2240.
8. Nombela-Arrieta, C., R. A. Lacalle, M. C. Montoya, Y. Kunisaki, D. Megias, M. Marques, A. C. Carrera, S. Manes, Y. Fukui, A. C. Martinez, and J. V. Stein. 2004. Differential requirements for DOCK2 and phosphoinositide-3-kinase γ during T and B lymphocyte homing. Immunity 21: 429-441.
9. Nombela-Arrieta, C., T. R. Mempel, S. F. Soriano, I. Mazo, M. P. Wymann, E. Hirsch, A. C. Martinez, Y. Fukui, U. H. von Andrian, and J. V. Stein. 2007. A central role for DOCK2 during interstitial lymphocyte motility and sphingosine-1-phosphate-mediated egress. J. Exp. Med. 204: 497-510.
10. Huang, Y. E., M. Iijima, C. A. Parent, S. Funamoto, R. A. Firtel, and P. Devreotes. 2003. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol. Biol. Cell 14: 1913-1922.
11. Curnock, A. P., Y. Sotsios, K. L. Wright, and S. G. Ward. 2003. Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinases. J. Immunol. 170: 4021-4030.
12. 2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase. Am. J. Respir. Cell Mol. Biol. 33: 65-70.
13. Munugalavadla, V., J. Borneo, D. A. Ingram, and R. Kapur. 2005. p85alpha; subunit of class IA PI-3 kinase is crucial for macrophage growth and migration. Blood 106: 103-109.
14. Perez, O. D., S. Kinoshita, Y. Hitoshi, D. G. Payan, T. Kitamura, G. P. Nolan, and J. B. Lorens. 2002. Activation of the PKB/AKT pathway by ICAM-2. Immunity 16: 51-65.
15. Khwaja, A., K. Lehmann, B. M. Marte, and J. Downward. 1998. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem. 273: 18793-18801.
16. Ortolano, S., I. Y. Hwang, S. B. Han, and J. H. Kehrl. 2006. Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing. Eur. J. Immunol. 36: 1285-1295.
17. Jimenez, C., R. A. Portela, M. Mellado, J. M. Rodriguez-Frade, J. Collard, A. Serrano, A. C. Martinez, J. Avila, and A. C. Carrera. 2000. Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J. Cell Biol. 151: 249-262.
18. 2+ imaging. Cell Calcium 30: 389-393.
19. Miller, M. J., S. H. Wei, I. Parker, and M. D. Cahalan. 2002. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296: 1869-1873.
20. Fruman, D. A., F. Mauvais-Jarvis, D. A. Pollard, C. M. Yballe, D. Brazil, R. T. Bronson, C. R. Kahn, and L. C. Cantley. 2000. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 α. Nat. Genet. 26: 379-382.
21. Brachmann, S. M., C. M. Yballe, M. Innocenti, J. A. Deane, D. A. Fruman, S. M. Thomas, and L. C. Cantley. 2005. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol. Cell. Biol. 25: 2593-2606.
22. Orban, P. C., D. Chui, and J. D. Marth. 1992. Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA 89: 6861-6865.
23. Cyster, J. G., V. N. Ngo, E. H. Ekland, M. D. Gunn, J. D. Sedgwick, and K. M. Ansel. 1999. Chemokines and B-cell homing to follicles. Curr. Top. Microbiol. Immunol. 246: 87-92; discussion 93.
24. Hess, K. L., A. C. Donahue, K. L. Ng, T. I. Moore, J. Oak, and D. A. Fruman. 2004. Frontline: The p85α isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses. Eur. J. Immunol. 34: 2968-2976.
25. Deane, J. A., M. G. Kharas, J. S. Oak, L. N. Stiles, J. Luo, T. I. Moore, H. Ji, C. Rommel, L. C. Cantley, T. E. Lane, and D. A. Fruman. 2007. T cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 109: 2894-2902.
26. Oak, J. S., J. A. Deane, M. G. Kharas, J. Luo, T. E. Lane, L. C. Cantley, and D. A. Fruman. 2006. Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. USA 103: 16882-16887.
27. Vanhaesebroeck, B., G. E. Jones, W. E. Allen, D. Zicha, R. Hooshmand-Rad, C. Sawyer, C. Wells, M. D. Waterfield, and A. J. Ridley. 1999. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat. Cell. Biol. 1: 69-71.
28. Reif, K., E. H. Ekland, L. Ohl, H. Nakano, M. Lipp, R. Forster, and J. G. Cyster. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416: 94-99.
29. Ansel, K. M., R. B. Harris, and J. G. Cyster. 2002. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16: 67-76.
30. Han, S. B., C. Moratz, N. N. Huang, B. Kelsall, H. Cho, C. S. Shi, O. Schwartz, and J. H. Kehrl. 2005. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 22: 343-354.
31. Tilton, B., L. Ho, E. Oberlin, P. Loetscher, F. Baleux, I. Clark-Lewis, and M. Thelen. 2000. Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J. Exp. Med. 192: 313-324.
32. Honczarenko, M., R. S. Douglas, C. Mathias, B. Lee, M. Z. Ratajczak, and L. E. Silberstein. 1999. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 94: 2990-2998.
33. D'Apuzzo, M., A. Rolink, M. Loetscher, J. A. Hoxie, I. Clark-Lewis, F. Melchers, M. Baggiolini, and B. Moser. 1997. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27: 1788-1793.
34. Yamamoto, D., Y. Sonoda, M. Hasegawa, M. Funakoshi-Tago, E. Aizu-Yokota, and T. Kasahara. 2003. FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways. Cell. Signal. 15: 575-583.
35. Zhang, S., and H. E. Broxmeyer. 1999. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells. Biochem. Biophys. Res. Commun. 254: 440-445.
36. Fedyk, E. R., D. H. Ryyan, I. Ritterman, and T. A. Springer. 1999. Maturation decreases responsiveness of human bone marrow B lineage cells to stromalderived factor 1 (SDF-1) J. Leukocyte Biol. 66: 667-673.
37. von Andrian, U. H., and T. R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3: 867-878.
38. Donahue, A. C., K. L. Hess, K. L. Ng, and D. A. Fruman. 2004. Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha;. Int. Immunol. 16: 1789-1798.
39. Welch, H. C., W. J. Coadwell, L. R. Stephens, and P. T. Hawkins. 2003. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett. 546: 93-97.
40. Fruman, D. A., S. B. Snapper, C. M. Yballe, L. Davidson, J. Y. Yu, F. W. Alt, and L. C. Cantley. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283: 393-397.
41. Lee, M. J., S. Thangada, J. H. Paik, G. P. Sapkota, N. Ancellin, S. S. Chae, M. Wu, M. Morales-Ruiz, W. C. Sessa, D. R. Alessi, and T. Hla. 2001. Aktmediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell 8: 693-704.
42. Igarashi, J., and T. Michel. 2001. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase β. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways. J. Biol. Chem. 276: 36281-36288.